Results from a prospective clinical study show that the GeneSearch™ Breast Lymph Node (BLN) Assay, a gene-based diagnostic test has greater sensitivity than traditional intra-operative methods ...

And through what mechanisms do SGLT2 inhibitors cut CV risk, anyway? ... Assay Panel May Predict SGLT2 Inhibitor Response in High CV-Risk Diabetes. Steve Stiles. June 30, 2021.